The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ziv-aflibercept in combination with FOLFIRI for 2nd-line treatment of patients with metastatic colorectal cancer: Interim safety data from the global aflibercept safety and quality-of-life program (ASQoP/AFEQT) in patients age 65 and older.
 
Roberto Bordonaro
Honoraria - Proacta; Sanofi
Consulting or Advisory Role - Proacta; Sanofi
Speakers' Bureau - Novartis; Roche Pharma AG; Sanofi
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Luca Frassineti
No Relationships to Disclose
 
Libero Ciuffreda
No Relationships to Disclose
 
Giuseppe Aprile
Consulting or Advisory Role - Amgen; Lilly; Merck; Roche Pharma AG; Sanofi
Speakers' Bureau - Amgen; Lilly; Merck; Roche Pharma AG; Sanofi
 
Anne L. Thomas
No Relationships to Disclose
 
Raghu Vishwanath
Employment - Sanofi
Leadership - Sanofi
 
Chiara Zilocchi
Employment - Sanofi
 
Emmanuelle Dochy
Employment - Sanofi
Leadership - Sanofi
 
Julien Taïeb
Honoraria - Sanofi
Consulting or Advisory Role - Sanofi
 
Alberto F. Sobrero
Honoraria - Amgen; Bayer; Celgene; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck; Roche Pharma AG; Sanofi